COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS
Publication
, Conference
HERSHFIELD, MS; CHAFFEE, S; KOROJOHNSON, L; SHORT, S
Published in: CLINICAL RESEARCH
April 1, 1990
Duke Scholars
Published In
CLINICAL RESEARCH
ISSN
0009-9279
Publication Date
April 1, 1990
Volume
38
Issue
2
Start / End Page
A457 / A457
Publisher
SLACK INC
Citation
APA
Chicago
ICMJE
MLA
NLM
HERSHFIELD, M. S., CHAFFEE, S., KOROJOHNSON, L., & SHORT, S. (1990). COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS. In CLINICAL RESEARCH (Vol. 38, pp. A457–A457). SLACK INC.
HERSHFIELD, M. S., S. CHAFFEE, L. KOROJOHNSON, and S. SHORT. “COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS.” In CLINICAL RESEARCH, 38:A457–A457. SLACK INC, 1990.
HERSHFIELD MS, CHAFFEE S, KOROJOHNSON L, SHORT S. COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS. In: CLINICAL RESEARCH. SLACK INC; 1990. p. A457–A457.
HERSHFIELD, M. S., et al. “COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS.” CLINICAL RESEARCH, vol. 38, no. 2, SLACK INC, 1990, pp. A457–A457.
HERSHFIELD MS, CHAFFEE S, KOROJOHNSON L, SHORT S. COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS. CLINICAL RESEARCH. SLACK INC; 1990. p. A457–A457.
Published In
CLINICAL RESEARCH
ISSN
0009-9279
Publication Date
April 1, 1990
Volume
38
Issue
2
Start / End Page
A457 / A457
Publisher
SLACK INC